Vestal Point Capital, LP

Position in WGS — GeneDx Holdings Corp.

CIK 1974915 NEW YORK, NY

Position in WGS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$16,055,000

New position

Shares Held

250,000

first reported quarter

Ownership

0.842%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vestal Point Capital, LP holds $57,460,428 across 4 Diagnostics & Research names. WGS ranks #2 (27.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	WAT	Waters Corp /De/	100,000	$29,780,000
2	WGS	GeneDx Holdings Corp. This page	250,000	$16,055,000
3	MYGN	Myriad Genetics Inc	1,648,000	$7,416,000
4	VCYT	Veracyte, Inc.	130,687	$4,209,428

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,055,000	250,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.